StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Stage0

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon May 01, 2024 10:46am

82 Views

Post# 36017209

RE:RE:Stage0

WillHey wrote: i didnt get to see the comment on my post. They worked fast to get it removed!

Here is a modified version:
"Yah nailed it. If szls ever resumes trading it will likely hit one half a cent before going belly up. Somebody needs to be held accountable for this outrageous non-product called Aristotle."

<< Previous

Bullboard Posts

Next >>

AI companies to invest in